Abstract
Despite the existence of clinical and biochemical features that can influence sociopsychological condition, in adolescent girls with PCOS, social abilities and sex-typical behaviours do not seem to be disturbed.
Introduction
Polycystic Ovary Syndrome (PCOS) is the most common endocrine disorder in women of reproductive age, affecting approximately 5–7% of the population. Characterized by irregular menstruation, polycystic ovaries, and hyperandrogenism, the syndrome often presents with physical symptoms such as acne, weight gain, and hirsutism. In a societal context where femininity is often tied to specific aesthetic standards, these symptoms can be psychologically distressing. While adult women with PCOS frequently report a lower quality of life and a diminished sense of femininity, the impact on adolescent girls—who are in a critical window of personality and social development—is less understood. This pilot study investigates whether the clinical features of PCOS interfere with social competence or psychological gender identity during these formative years.
Methodology
The researchers conducted a pilot study at the Medical University of Silesia, comparing 28 adolescent girls diagnosed with PCOS (mean age ~17.1) against a control group of 12 healthy, age- and BMI-matched peers. Participants underwent clinical and hormonal profiling, including transabdominal pelvic ultrasounds and blood tests for sex steroids.
Psychosocial assessment was performed using two primary instruments:
- Social Competence Inventory (SCI): A self-report questionnaire measuring three domains: Intimacy (forming close relationships), Self-Presentation (behavior in formal situations), and Assertiveness (influencing others).
- Psychological Gender Inventory (PGI): Based on Sandra Bem’s Gender Schema Theory, this test assesses identification with feminine and masculine characteristics to determine psychological gender identity.
Clinical and Biochemical Profile
The study group exhibited significant clinical and biochemical differences compared to the control group. Notably, girls with PCOS had significantly higher testosterone levels (66.1 vs. 42.2 ng/dL, p=0.04) and higher Ferriman-Gallwey scores, which measure the severity of hirsutism (10.0 vs. 1.0, p < 0.001). Cycle duration was also significantly longer in the PCOS group (36.5 vs. 32.0 days, p=0.03).
Psychosocial Outcomes
Despite the marked hormonal and physical differences, the researchers found no statistically significant differences between the PCOS and control groups regarding social competence or psychological gender identity. Both groups scored similarly across all SCI categories, including Intimacy, Self-Presentation, and Assertiveness. Furthermore, the distribution of gender identities remained consistent; for instance, 42.9% of the PCOS group identified as a "feminine woman" compared to 33.3% of the control group (p > 0.05).
Discussion and Insights
The most striking finding is the psychological resilience observed in adolescent girls with PCOS. The authors propose a "duration of exposure" hypothesis: because these patients are young, they may not have been exposed to the distressing symptoms of PCOS long enough for their self-image to erode. This contrasts with findings in older women, where the chronic nature of the syndrome often leads to a sense of being "undifferentiated" in gender roles.
However, the study did find a significant negative correlation between testosterone levels and both social competence (r = –0.5, p = 0.01) and assertiveness (r = –0.5, p = 0.02). This suggests that while group-level scores remain stable, elevated androgens in female adolescence might hinder social confidence, potentially due to the psychological stress associated with physical symptoms.
Conclusion
This pilot study suggests that social competencies and gender role identification are not significantly disturbed in the early stages of PCOS during adolescence. While the small sample size (n=40) limits generalizability, the findings highlight a window of psychological stability. Longitudinal research is needed to determine if early clinical intervention can prevent the decline in quality of life often observed as PCOS patients transition into adulthood.
Summary updated